The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...

A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for ...

An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over 12 months, whereas placebo patients worsened. Those with high-risk ...

Today’s cough syrup could turn into tomorrow’s treatment for Parkinson’s disease. Recent research in the U.K. is the latest to suggest that a common ingredient in cough syrup, ambroxol, might be able ...

Ambroxol, a common cough medicine used in Europe, demonstrated target engagement in people with Parkinson's disease dementia but did not show an effect on cognition compared with placebo, a year ...

A cough medicine used for decades in Europe called ambroxol has shown promise for treating dementia in people with Parkinson's disease. The corresponding study was published in JAMA Neurology. People ...

Ambroxol was safe, well-tolerated and reached therapeutic levels in the brain. Psychiatric symptoms worsened in the placebo group but remained stable in those taking Ambroxol.

“We hope that Ambroxol, or drugs like Ambroxol, will be able to prevent the onset of Parkinson's disease and dementia if it is given early enough,” Dr Stephen Pasternak told The Standard.